Elizabeth S. Frank

机构：Breast Cancer Alliance, Dana-Farber Cancer Institute · ORCID：0000-0001-9268-5104

发表论文 107 篇 · 总被引 2783 次 · h-index 22

代表论文

• Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ (2024 · JAMA · 被引 83)
• Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update (2024 · Journal of Clinical Oncology · 被引 37)
• User-centered design and agile development of a novel mobile health application and clinician dashboard to support the collection and reporting of patient-reported outcomes for breast cancer care (2022 · BMJ Surgery Interventions & Health Technologies · 被引 29)
• The Metastatic Breast Cancer Project: leveraging patient-partnered research to expand the clinical and genomic landscape of metastatic breast cancer and accelerate discoveries (2023 · medRxiv · 被引 25)
• Patient perspectives on testing for clonal hematopoiesis of indeterminate potential (2022 · Blood Advances · 被引 14)
• Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer (2025 · JAMA Oncology · 被引 11)